Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Dorothea Hanf

1PUBLICATIONS

8CO-AUTHORS

Reaction engineering (excl. nuclear reactions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 12, 2021

Response to Cabozantinib Following Acquired Entrectinib Resistance in a Patient With <i>ETV6-NTRK3</i> Fusion-Positive Carcinoma Harboring the <i>NTRK3</i> <sup>G623R</sup> Solvent-Front Mutation.

Dorothea Hanf, Christoph Heining, Karin Laaber

Pageof 1

Frequent Collaborators

1 joint publications

Karin Laaber

1 joint publications

Heiner Nebelung

1 joint publications

Sebastian Uhrig

1 joint publications

Arne Jahn

1 joint publications

Daniela Aust

1 joint publications

Friederike Herbst

1 joint publications

Stefan Fröhling

1 joint publications

Gunnar Folprecht

Frequent Collaborators

1 joint publications

Karin Laaber

1 joint publications

Heiner Nebelung

1 joint publications

Sebastian Uhrig

1 joint publications

Arne Jahn

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos